Daniel M. Labow

Daniel M. Labow is chief of the Division of Surgical Oncology at the Mount Sinai Hospital, New York, as well as associate professor of surgery and surgical oncology at the Mount Sinai School of Medicine. He is considered a pioneer in cytoreductive and intraperitoneal hyperthermic chemoperfusion (HIPEC).
Labow is an active researcher concentrating on the diagnosis and treatment for a range of primary and metastatic malignances and minimally invasive treatments.
He is a diplomat of the American Board of Surgery and the National Board of Medical Examiners. He was listed as a New York Metro area top doctor in 2011 and is a New York State Chair for the American College of Surgeons.
Biography
Labow received his M.D. from the Brown-Dartmouth Medical Program at the Brown University School of Medicine in 1995. radiofrequency ablation, soft tissue sarcoma, stomach cancer, and HIPEC.<ref name=MSH/>
Professional appointments
*2013 - GI Committee Disease Focus Group Co-Chair, Mount Sinai Hospital
*2011 - Case Reports in Surgery, editorial board
*2011 - Committee on Cancer State Chair for Manhattan
*2010 - Tumor Task Force, Unusual Presentations and Specialized Procedures, Society of Surgical Oncology
*2009 - Liver Cancer Program member
*2009 - Fellowship Training Committee, Society of Surgical Oncology
*2008 - Tisch Cancer Institute Committee member
Publications
the Web of Science lists 23 peer-reviewed publications authored by Labow that have been cited 338 times, giving him an h-index of 9. The three most-highest-cited ones are:
*
*
*

Main Menu

See Also

Main Menu